Author

Pujan Sasmal

Observed name: Sasmal, Pujan

Institutions: National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research

Observed institutions: National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, Calcutta Institute of Pharmaceutical Technology & Allied Health Sciences

ORCID: 0000-0002-6421-8397

Observed ORCID: 0000-0002-6421-8397

OpenAlex ID: A5028957451

Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interaction

2022 · Pujan Sasmal, Sajeev Kumar Babasahib, et al. · Bioorganic & Medicinal Chemistry · 35

Aza- ortho -Quinone Methide Promoted Strain-Release-Driven Conversion of Azabicyclo[1.1.0]butanes into Functionalized Azetidines

2024 · Bandana Singh, Pujan Sasmal, et al. · Organic Letters · 29

HFIP-Promoted Strain-Release-Driven Functionalization of Azabicyclo[1.1.0]butanes with Heterocyclobutane Trichloroacetimidates

2026 · Pujan Sasmal, Subhadeep Hazra, et al. · Organic Letters · 10

Lewis Acid Catalyzed Dual Strain-Release Platform for Transforming Azabicyclo[1.1.0]butanes into Functionalized Azetidines with Donor–Acceptor(D-A) Cyclopropanes and Bicyclo[1.1.0]butanes

2026 · Subhadeep Hazra, Manveer Patel, et al. · Organic Letters · 9

Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancer

2022 · Prasad Sanjay Dhiwar, Gurubasavaraja Swamy Purwarga Matada, et al. · Medicinal Chemistry Research · 9

Designing Studies in Pharmaceutical and Medicinal Chemistry

2023 · N. M. Raghavendra, B. R. Prashantha Kumar, et al. · Springer eBooks · 8

Computational analysis of natural product B-Raf inhibitors

2022 · Sumiran Chettri, Pujan Sasmal, et al. · Journal of Molecular Graphics and Modelling · 8

Beyond peptides: Unveiling the design strategies, structure activity correlations and protein-ligand interactions of small molecule inhibitors against PD-1/PD-L1

2024 · Pujan Sasmal, P. Prabitha, et al. · Bioorganic Chemistry · 7

Biological evaluation of Ficus elastica leaves for antidepressant and anxiolytic activity

2023 · Akash Koley, Shyamal Kumar Biswas, et al. · Drug Discovery · 2

Merging strain-release functionalization with ortho -quinone-methide ( o -QM): modular access to N -functionalized azetidines

2026 · Pujan Sasmal, Aaron Taites, et al. · Organic Chemistry Frontiers · 1

Aza-ortho-Quinone Methide Promoted Strain-Release-Driven Conversion of Azabicyclo[1.1.0]butanes into Functionalized Azetidines

2026 · Pujan Sasmal, Bandana Singh, et al.

Rapid access to highly functionalized thietanes via electrophilic thietanylation under metal-free conditions

2026 · Neha Rajendra Thakar, Pujan Sasmal, et al. · Organic Chemistry Frontiers

Design and Discovery of Lophine Derivatives as Multi-targeting Agents by Molecular Docking, Admet, Md Simulation and Pharmacophore Analysis: a Computational Approach

2024 · Pujan Sasmal, Shyamal Kumar Biswas, et al. · Turkish computational and theoretical chemistry/Turkish computational and theoretical chemistry :

WITHDRAWN: Design and Discovery of Lophine Derivatives as Multitargeting Agents by Molecular Docking, ADMET, MD Simulation and Pharmacophore Analysis: A Computational Approach

2023 · Shyamal Kumar Biswas, Pujan Sasmal, et al. · Combinatorial Chemistry & High Throughput Screening

Works count: 18

Citation count: 118

H-index: 7

I10-index: 3